AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $475 | +6.5% | 6,800 | +9.7% | 0.00% | +50.0% |
| Q2 2023 | $446 | +29.3% | 6,200 | +10.7% | 0.00% | 0.0% |
| Q1 2023 | $345 | +6.5% | 5,600 | +33.3% | 0.00% | 0.0% |
| Q4 2022 | $324 | -99.9% | 4,200 | -35.4% | 0.00% | 0.0% |
| Q3 2022 | $290,000 | +16.5% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $249,000 | -19.7% | 6,500 | -13.3% | 0.00% | 0.0% |
| Q1 2022 | $310,000 | +9.5% | 7,500 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $283,000 | +38.7% | 7,500 | +21.0% | 0.00% | 0.0% |
| Q3 2021 | $204,000 | -51.2% | 6,200 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $418,000 | +22.9% | 6,200 | +3.3% | 0.00% | 0.0% |
| Q1 2021 | $340,000 | -30.5% | 6,000 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $489,000 | +14.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $428,000 | -56.7% | 6,000 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $988,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |